Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-16
1989-01-10
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514523, 514654, 514812, A61K 3144, A61K 31275, A61K 31135
Patent
active
047974109
ABSTRACT:
A method for suppressing withdrawal symptoms in an opioid-induced tolerant or physically dependent individual is disclosed. The method comprises administering to such individual an effective amount of a calcium channel blocking drug or pharmaceutically acceptable non-toxic salt thereof to suppress said withdrawal in said individual. Also disclosed are pharmaceutical compositions suitable for use in suppressing withdrawal symptoms in an opioid-induced tolerant or physically dependent individual.
REFERENCES:
Calcium Blockers, Flaim et al, Urban & Schwarzenberg, Baltimore-Munich, 1982, pp. 186-189, 196 & 197.
Boguslaski M. G.
Gray E. P.
Miles Inc.
Waddell Frederick E.
LandOfFree
Suppression of withdrawal symptoms in opioid-induced tolerance o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of withdrawal symptoms in opioid-induced tolerance o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of withdrawal symptoms in opioid-induced tolerance o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2108009